Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.085 USD | +0.82% | -3.30% | +52.23% |
May. 10 | Leerink Partners Starts Aquestive Therapeutics With Outperform Rating, $8 Price Target | MT |
May. 08 | Transcript : Aquestive Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+52.23% | 279M | |
+37.91% | 727B | |
-7.92% | 354B | |
+15.43% | 328B | |
-0.43% | 277B | |
+13.47% | 243B | |
+7.35% | 205B | |
-6.42% | 203B | |
+3.91% | 164B | |
-2.05% | 164B |
- Stock Market
- Equities
- AQST Stock
- News Aquestive Therapeutics, Inc.
- Earnings Flash (AQST) AQUESTIVE THERAPEUTICS Posts Q1 Revenue $12.1M, vs. Street Est of $12.3M